NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
17.37
+0.58 (3.45%)
At close: Aug 26, 2026, 4:00 PM EDT
17.56
+0.19 (1.09%)
Pre-market: Aug 27, 2026, 6:32 AM EDT
NeoGenomics Employees
NeoGenomics had 2,500 employees as of December 31, 2025. The number of employees increased by 300 or 13.64% compared to the previous year.
Employees
2,500
Change (1Y)
300
Growth (1Y)
13.64%
Revenue / Employee
$306,518
Profits / Employee
-$20,751
Market Cap
2.23B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2,500 | 300 | 13.64% |
| Dec 31, 2024 | 2,200 | 100 | 4.76% |
| Dec 31, 2023 | 2,100 | 0 | - |
| Dec 31, 2022 | 2,100 | 100 | 5.00% |
| Dec 31, 2021 | 2,000 | 300 | 17.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sotera Health Company | 3,000 |
| OPKO Health | 2,275 |
| GeneDx Holdings | 1,300 |
| Castle Biosciences | 1,002 |
| GRAIL | 910 |
| CareDx | 765 |
| Veracyte | 755 |
| Adaptive Biotechnologies | 624 |
NEO News
- 14 hours ago - NeoGenomics receives Medicare coverage for RaDaR ST MRD assay - TheFly
- 14 hours ago - NeoGenomics Receives Medicare Coverage for RaDaR ST for Immunotherapy Treatment Response Monitoring - Business Wire
- 4 weeks ago - NeoGenomics price target raised to $19 from $17 at Craig-Hallum - TheFly
- 4 weeks ago - NeoGenomics price target raised to $19 from $15 at Needham - TheFly
- 4 weeks ago - NeoGenomics Earnings Call Transcript: Q2 2026 - Transcripts
- 4 weeks ago - NeoGenomics Earnings release: Q2 2026 - Filings
- 4 weeks ago - NeoGenomics Quarterly report: Q2 2026 - Filings
- 4 weeks ago - NeoGenomics Slides: Q2 2026 - Filings